Glooko provides digital health platforms and data management tools for diabetes care.
Glooko has raised $100.0M in total funding. The most recent round was Series F. The last funding was announced in October 2024.
Glooko's investors include Canaan Partners, Georgian, Samsung NEXT, Novo Nordisk, Glooko.
Glooko is headquartered in Palo Alto, United States.
Glooko provides digital health platforms and data management tools for diabetes care.
Glooko is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Glooko — Funding & Investors." VCBacked, October 10, 2024, https://www.vcbacked.co/company/glooko. Accessed November 11, 2026.
VCBacked. (2024). Glooko — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/glooko
{{cite web |title=Glooko — Funding & Investors |url=https://www.vcbacked.co/company/glooko |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Glooko? Request a listing update